ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

被引:0
|
作者
Wing-Lok Chan
机构
[1] The University of Hong Kong,Department of Clinical Oncology, LKS Faculty of Medicine
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:871 / 872
页数:1
相关论文
共 50 条
  • [1] ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 871 - 872
  • [2] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Cheuk-Wai Choi
    Ian Yu-Hong Wong
    Terence Hon-Ting Tsang
    Adrian Tin-Chung Lam
    Rosa Pui-Ying Tse
    K. K. Chan
    Claudia Wong
    Betty Tze-Ting Law
    Emina Edith Cheung
    Siu-Yin Chan
    Ka-On Lam
    Dora Kwong
    Simon Law
    [J]. Annals of Surgical Oncology, 2023, 30 : 861 - 870
  • [3] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    Choi, Cheuk-Wai
    Wong, Ian Yu-Hong
    Tsang, Terence Hon-Ting
    Lam, Adrian Tin-Chung
    Tse, Rosa Pui-Ying
    Chan, K. K.
    Wong, Claudia
    Law, Betty Tze-Ting
    Cheung, Emina Edith
    Chan, Siu-Yin
    Lam, Ka-On
    Kwong, Dora
    Law, Simon
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 861 - 870
  • [4] ASO Author Reflections: Enhancing Treatment Outcomes in Unresectable Esophageal Squamous Cell Carcinoma Through Immunochemotherapy
    Huang, Shujie
    Wang, Sichao
    Gao, Zhen
    Qiao, Guibin
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [5] ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
    Hiroshi Okumura
    Masahiro Noda
    Shoji Natsugoe
    [J]. Annals of Surgical Oncology, 2018, 25 : 715 - 716
  • [6] ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
    Okumura, Hiroshi
    Noda, Masahiro
    Natsugoe, Shoji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 715 - 716
  • [7] ASO Author Reflections: Esophageal Squamous Cell Carcinoma—Still a Conundrum
    M. Hart Squires
    Jonathan C. Salo
    [J]. Annals of Surgical Oncology, 2022, 29 : 1334 - 1335
  • [8] ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma
    Okamura, Akihiko
    Watanabe, Masayuki
    Okui, Jun
    Matsuda, Satoru
    Takemura, Ryo
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Muto, Manabu
    Kakeji, Yoshihiro
    Kitagawa, Yuko
    Doki, Yuichiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2186 - 2187
  • [9] ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma
    Kanie, Yasukazu
    Okamura, Akihiko
    Watanabe, Masayuki
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7997 - 7998
  • [10] ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma
    Yasukazu Kanie
    Akihiko Okamura
    Masayuki Watanabe
    [J]. Annals of Surgical Oncology, 2021, 28 : 7997 - 7998